These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23836971)

  • 1. Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.
    Jiang YR; Zhang ZH; Liu QY; Hu SY; Chen XY; Jia XB
    Int J Nanomedicine; 2013; 8():2285-93. PubMed ID: 23836971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.
    Yan HM; Sun E; Cui L; Jia XB; Jin X
    J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188.
    Yan HM; Zhang ZH; Jiang YR; Ding DM; Sun E; Jia XB
    Pharmacogn Mag; 2014 Apr; 10(Suppl 2):S311-7. PubMed ID: 24991109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced dissolution and stability of Tanshinone IIA base by solid dispersion system with nano-hydroxyapatite.
    Jiang YR; Zhang ZH; Huang SY; Lu Y; Ma TT; Jia XB
    Pharmacogn Mag; 2014 Jul; 10(39):332-7. PubMed ID: 25210322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan.
    Liu QY; Zhang ZH; Jin X; Jiang YR; Jia XB
    J Pharm Pharmacol; 2013 Jun; 65(6):839-46. PubMed ID: 23647677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Potential of Mesoporous Silica as a Carrier for Puerarin: Characterization, Physical Stability, and In Vivo Pharmacokinetics.
    Wang Z; Ye BN; Zhang YT; Xie JX; Li WS; Zhang HT; Liu Y; Feng NP
    AAPS PharmSciTech; 2019 Aug; 20(7):289. PubMed ID: 31414349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
    Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
    Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo.
    Guan H; Wang M; Yu S; Wang C; Chen Q; Chen Y; Zhang W; Fan J
    J Pharm Sci; 2024 Oct; 113(10):3045-3053. PubMed ID: 39094942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and Stability of Tanshinone IIA Solid Dispersions with Hydroxyapatite.
    Wang X; Li L; Huo W; Hou L; Zhao Z; Li W
    Materials (Basel); 2013 Mar; 6(3):805-816. PubMed ID: 28809341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
    Zhao X; Liu X; Gan L; Zhou C; Mo J
    Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of different preparation methods of tanshinoneporous silica solid dispersion].
    Jiang YR; Zhang ZH; Ding DM; Chen XY; Su E; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(19):3271-6. PubMed ID: 24422390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.
    Varshosaz J; Dayani L; Chegini SP; Minaiyan M
    IET Nanobiotechnol; 2019 Jun; 13(4):392-399. PubMed ID: 31171744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
    Xu WJ; Xie HJ; Cao QR; Shi LL; Cao Y; Zhu XY; Cui JH
    Drug Deliv; 2016; 23(1):41-8. PubMed ID: 24735247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
    Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
    Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
    Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
    Kim MS; Kim JS; Park HJ; Cho WK; Cha KH; Hwang SJ
    Int J Nanomedicine; 2011; 6():2997-3009. PubMed ID: 22162657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.